CHMI(CHMI)
CHMI
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $39M | $44M |
| Low | $29M | $33M |
| High | $48M | $55M |
| EBITDA Avg | $21M | $25M |
| Low | $16M | $18M |
| High | $27M | $31M |
| EBIT Avg | $19M | $22M |
| Low | $14M | $16M |
| High | $24M | $27M |
| Net Income Avg | $22M | $22M |
| Low | $14M | $14M |
| High | $27M | $26M |
| EPS Avg | $0.56 | $0.55 |
| Low | $0.38 | $0.37 |
| High | $0.73 | $0.73 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $11M | $11M | $9M | $10M | $10M | $9M |
| Low | $10M | $10M | $8M | $9M | $9M | $8M |
| High | $12M | $12M | $10M | $11M | $11M | $10M |
| EBITDA Avg | $6M | $6M | $5M | $5M | $5M | $5M |
| Low | $6M | $5M | $5M | $5M | $5M | $5M |
| High | $7M | $7M | $6M | $6M | $6M | $6M |
| EBIT Avg | $5M | $5M | $4M | $5M | $5M | $5M |
| Low | $5M | $5M | $4M | $4M | $4M | $4M |
| High | $6M | $6M | $5M | $5M | $5M | $5M |
| Net Income Avg | $5M | $5M | $5M | $5M | $5M | $5M |
| Low | $4M | $4M | $4M | $4M | $4M | $4M |
| High | $6M | $5M | $6M | $6M | $6M | $6M |
| EPS Avg | $0.14 | $0.13 | $0.14 | $0.14 | $0.14 | $0.14 |
| Low | $0.12 | $0.11 | $0.12 | $0.12 | $0.12 | $0.12 |
| High | $0.16 | $0.15 | $0.15 | $0.16 | $0.16 | $0.15 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |